Sanofi-Aventis China R&D Head Frank Jiang On Forming A Fully Integrated Drug R&D Platform In China: An Interview With Pharmasia News

Sanofi-Aventis opened its doors in Shanghai in June 2005 with its China Clinical Research Unit, established to conduct high-quality clinical trials that would pass regulatory muster worldwide. The company recently expanded its R&D presence in the country by broadening its activities. Sanofi VP and China R&D Head Frank Jiang talked to PharmAsia News' Shanghai bureau about Sanofi's R&D strategy in China.